nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—amyotrophic lateral sclerosis	0.578	1	CbGaD
Bumetanide—SLC12A5—peripheral nervous system—amyotrophic lateral sclerosis	0.0207	0.0949	CbGeAlD
Bumetanide—SLC12A5—nerve—amyotrophic lateral sclerosis	0.0161	0.074	CbGeAlD
Bumetanide—SLC12A5—hindbrain—amyotrophic lateral sclerosis	0.0121	0.0554	CbGeAlD
Bumetanide—SLC12A1—appendage—amyotrophic lateral sclerosis	0.0109	0.0501	CbGeAlD
Bumetanide—SLC12A4—hindbrain—amyotrophic lateral sclerosis	0.01	0.046	CbGeAlD
Bumetanide—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00796	0.0882	CcSEcCtD
Bumetanide—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00758	0.084	CcSEcCtD
Bumetanide—SLC12A5—brainstem—amyotrophic lateral sclerosis	0.00692	0.0318	CbGeAlD
Bumetanide—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0714	CcSEcCtD
Bumetanide—SLC12A4—embryo—amyotrophic lateral sclerosis	0.00627	0.0288	CbGeAlD
Bumetanide—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0687	CcSEcCtD
Bumetanide—SLC12A4—brainstem—amyotrophic lateral sclerosis	0.00575	0.0264	CbGeAlD
Bumetanide—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00522	0.0578	CcSEcCtD
Bumetanide—SLC12A5—medulla oblongata—amyotrophic lateral sclerosis	0.00483	0.0221	CbGeAlD
Bumetanide—SLC12A5—spinal cord—amyotrophic lateral sclerosis	0.0043	0.0198	CbGeAlD
Bumetanide—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00419	0.0192	CbGeAlD
Bumetanide—CA4—nerve—amyotrophic lateral sclerosis	0.00417	0.0191	CbGeAlD
Bumetanide—SLC12A2—brainstem—amyotrophic lateral sclerosis	0.00397	0.0182	CbGeAlD
Bumetanide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0421	CcSEcCtD
Bumetanide—SLC12A5—nervous system—amyotrophic lateral sclerosis	0.00363	0.0166	CbGeAlD
Bumetanide—PTGS2—appendage—amyotrophic lateral sclerosis	0.0036	0.0165	CbGeAlD
Bumetanide—SLC12A4—spinal cord—amyotrophic lateral sclerosis	0.00357	0.0164	CbGeAlD
Bumetanide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00352	0.039	CcSEcCtD
Bumetanide—SLC12A5—central nervous system—amyotrophic lateral sclerosis	0.00349	0.016	CbGeAlD
Bumetanide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0382	CcSEcCtD
Bumetanide—SLC12A5—cerebellum—amyotrophic lateral sclerosis	0.00341	0.0157	CbGeAlD
Bumetanide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0356	CcSEcCtD
Bumetanide—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0348	CcSEcCtD
Bumetanide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00312	0.0143	CbGeAlD
Bumetanide—SLC12A4—nervous system—amyotrophic lateral sclerosis	0.00301	0.0138	CbGeAlD
Bumetanide—SLC12A4—central nervous system—amyotrophic lateral sclerosis	0.0029	0.0133	CbGeAlD
Bumetanide—SLC12A4—cerebellum—amyotrophic lateral sclerosis	0.00283	0.013	CbGeAlD
Bumetanide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0028	0.031	CcSEcCtD
Bumetanide—SLC12A5—brain—amyotrophic lateral sclerosis	0.00277	0.0127	CbGeAlD
Bumetanide—SLC12A2—medulla oblongata—amyotrophic lateral sclerosis	0.00277	0.0127	CbGeAlD
Bumetanide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.00258	0.0119	CbGeAlD
Bumetanide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0274	CcSEcCtD
Bumetanide—SLC12A2—spinal cord—amyotrophic lateral sclerosis	0.00247	0.0113	CbGeAlD
Bumetanide—CA14—spinal cord—amyotrophic lateral sclerosis	0.0023	0.0106	CbGeAlD
Bumetanide—SLC12A4—brain—amyotrophic lateral sclerosis	0.0023	0.0106	CbGeAlD
Bumetanide—CA7—cerebellum—amyotrophic lateral sclerosis	0.00219	0.0101	CbGeAlD
Bumetanide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0243	CcSEcCtD
Bumetanide—SLC12A2—nervous system—amyotrophic lateral sclerosis	0.00208	0.00954	CbGeAlD
Bumetanide—SLC12A1—spinal cord—amyotrophic lateral sclerosis	0.00207	0.00949	CbGeAlD
Bumetanide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0227	CcSEcCtD
Bumetanide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0226	CcSEcCtD
Bumetanide—SLC12A2—central nervous system—amyotrophic lateral sclerosis	0.002	0.00918	CbGeAlD
Bumetanide—SLC10A1—nervous system—amyotrophic lateral sclerosis	0.00196	0.00901	CbGeAlD
Bumetanide—SLC12A2—cerebellum—amyotrophic lateral sclerosis	0.00196	0.00897	CbGeAlD
Bumetanide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0215	CcSEcCtD
Bumetanide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0215	CcSEcCtD
Bumetanide—CA9—cerebellum—amyotrophic lateral sclerosis	0.00193	0.00884	CbGeAlD
Bumetanide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0019	0.021	CcSEcCtD
Bumetanide—SLC10A1—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00867	CbGeAlD
Bumetanide—CA14—cerebellum—amyotrophic lateral sclerosis	0.00183	0.00838	CbGeAlD
Bumetanide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0202	CcSEcCtD
Bumetanide—CFTR—brain—amyotrophic lateral sclerosis	0.00181	0.0083	CbGeAlD
Bumetanide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0199	CcSEcCtD
Bumetanide—CA4—brainstem—amyotrophic lateral sclerosis	0.00179	0.00821	CbGeAlD
Bumetanide—CA7—brain—amyotrophic lateral sclerosis	0.00178	0.00817	CbGeAlD
Bumetanide—SLC12A1—nervous system—amyotrophic lateral sclerosis	0.00174	0.008	CbGeAlD
Bumetanide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0193	CcSEcCtD
Bumetanide—SLC12A1—central nervous system—amyotrophic lateral sclerosis	0.00168	0.0077	CbGeAlD
Bumetanide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0178	CcSEcCtD
Bumetanide—SLC12A2—brain—amyotrophic lateral sclerosis	0.00159	0.00729	CbGeAlD
Bumetanide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0169	CcSEcCtD
Bumetanide—CA12—nervous system—amyotrophic lateral sclerosis	0.00151	0.00695	CbGeAlD
Bumetanide—SLC10A1—brain—amyotrophic lateral sclerosis	0.0015	0.00689	CbGeAlD
Bumetanide—CA14—brain—amyotrophic lateral sclerosis	0.00148	0.00681	CbGeAlD
Bumetanide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0164	CcSEcCtD
Bumetanide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0163	CcSEcCtD
Bumetanide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00669	CbGeAlD
Bumetanide—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00141	0.00647	CbGeAlD
Bumetanide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00136	0.00623	CbGeAlD
Bumetanide—SLC22A7—brain—amyotrophic lateral sclerosis	0.00134	0.00614	CbGeAlD
Bumetanide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0148	CcSEcCtD
Bumetanide—SLC12A1—brain—amyotrophic lateral sclerosis	0.00133	0.00611	CbGeAlD
Bumetanide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0146	CcSEcCtD
Bumetanide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.00131	0.006	CbGeAlD
Bumetanide—SLC22A6—brain—amyotrophic lateral sclerosis	0.00129	0.00593	CbGeAlD
Bumetanide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0141	CcSEcCtD
Bumetanide—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00126	0.00577	CbGeAlD
Bumetanide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00125	0.00572	CbGeAlD
Bumetanide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0136	CcSEcCtD
Bumetanide—PTGS2—embryo—amyotrophic lateral sclerosis	0.00119	0.00548	CbGeAlD
Bumetanide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0131	CcSEcCtD
Bumetanide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00117	0.013	CcSEcCtD
Bumetanide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00117	0.013	CcSEcCtD
Bumetanide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0129	CcSEcCtD
Bumetanide—CA12—brain—amyotrophic lateral sclerosis	0.00116	0.00531	CbGeAlD
Bumetanide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00111	0.0051	CbGeAlD
Bumetanide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0122	CcSEcCtD
Bumetanide—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00106	0.00486	CbGeAlD
Bumetanide—CA5B—brain—amyotrophic lateral sclerosis	0.00104	0.00476	CbGeAlD
Bumetanide—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00102	0.00468	CbGeAlD
Bumetanide—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00101	0.00464	CbGeAlD
Bumetanide—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000997	0.00457	CbGeAlD
Bumetanide—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000974	0.00447	CbGeAlD
Bumetanide—CA4—nervous system—amyotrophic lateral sclerosis	0.000937	0.0043	CbGeAlD
Bumetanide—CA4—central nervous system—amyotrophic lateral sclerosis	0.000902	0.00414	CbGeAlD
Bumetanide—CA4—cerebellum—amyotrophic lateral sclerosis	0.000882	0.00405	CbGeAlD
Bumetanide—SLCO1A2—brain—amyotrophic lateral sclerosis	0.00081	0.00372	CbGeAlD
Bumetanide—SLC22A8—brain—amyotrophic lateral sclerosis	0.000773	0.00355	CbGeAlD
Bumetanide—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000764	0.0035	CbGeAlD
Bumetanide—CA4—brain—amyotrophic lateral sclerosis	0.000716	0.00329	CbGeAlD
Bumetanide—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000681	0.00312	CbGeAlD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00062	0.00544	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000595	0.00522	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000595	0.00522	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000588	0.00516	CbGpPWpGaD
Bumetanide—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000574	0.00263	CbGeAlD
Bumetanide—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000552	0.00253	CbGeAlD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000544	0.00478	CbGpPWpGaD
Bumetanide—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.00054	0.00248	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00053	0.00465	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.00053	0.00465	CbGpPWpGaD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000519	0.00455	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.000512	0.00449	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000492	0.00432	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000488	0.00429	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000485	0.00426	CbGpPWpGaD
Bumetanide—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000472	0.00414	CbGpPWpGaD
Bumetanide—CA14—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000465	0.00408	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000465	0.00408	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000453	0.00398	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000453	0.00398	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000443	0.00389	CbGpPWpGaD
Bumetanide—PTGS2—brain—amyotrophic lateral sclerosis	0.000439	0.00201	CbGeAlD
Bumetanide—CA14—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000425	0.00373	CbGpPWpGaD
Bumetanide—CA7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000423	0.00371	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000423	0.00371	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000423	0.00371	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000423	0.00371	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000417	0.00366	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000416	0.00365	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000415	0.00364	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000414	0.00364	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000403	0.00354	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000396	0.00348	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000395	0.00347	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000392	0.00344	CbGpPWpGaD
Bumetanide—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000392	0.00344	CbGpPWpGaD
Bumetanide—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000387	0.00339	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000387	0.00339	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000385	0.00338	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000385	0.00338	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000377	0.00331	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000373	0.00327	CbGpPWpGaD
Bumetanide—CA14—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000372	0.00326	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00037	0.00325	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000362	0.00318	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000362	0.00318	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00036	0.00316	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00036	0.00316	CbGpPWpGaD
Bumetanide—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000358	0.00315	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000354	0.0031	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000354	0.0031	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00035	0.00307	CbGpPWpGaD
Bumetanide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000347	0.00304	CbGpPWpGaD
Bumetanide—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000338	0.00297	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000338	0.00297	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000337	0.00296	CbGpPWpGaD
Bumetanide—CA14—Metabolism—DAO—amyotrophic lateral sclerosis	0.000336	0.00295	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000336	0.00295	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000333	0.00292	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000331	0.0029	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000331	0.0029	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000328	0.00287	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000328	0.00287	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000328	0.00287	CbGpPWpGaD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000326	0.00286	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000323	0.00284	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.00032	0.0028	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000317	0.00278	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000315	0.00277	CbGpPWpGaD
Bumetanide—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000314	0.00275	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000314	0.00275	CbGpPWpGaD
Bumetanide—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000313	0.00275	CbGpPWpGaD
Bumetanide—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000313	0.00274	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000313	0.00274	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000311	0.00273	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000308	0.0027	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	0.000306	0.00268	CbGpPWpGaD
Bumetanide—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000306	0.00268	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000305	0.00268	CbGpPWpGaD
Bumetanide—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000302	0.00265	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0003	0.00263	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000294	0.00258	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000289	0.00254	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000289	0.00254	CbGpPWpGaD
Bumetanide—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000286	0.00251	CbGpPWpGaD
Bumetanide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000283	0.00249	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000282	0.00248	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000281	0.00247	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000279	0.00244	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000275	0.00241	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000266	0.00233	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000264	0.00232	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000262	0.0023	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000261	0.00229	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000255	0.00224	CbGpPWpGaD
Bumetanide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000253	0.00222	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000253	0.00222	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000251	0.0022	CbGpPWpGaD
Bumetanide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00025	0.00219	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000248	0.00218	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000248	0.00218	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000245	0.00215	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.00024	0.0021	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000237	0.00208	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000236	0.00207	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	0.000235	0.00206	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000234	0.00205	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000232	0.00203	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000232	0.00203	CbGpPWpGaD
Bumetanide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000231	0.00203	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000229	0.00201	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000226	0.00198	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000225	0.00198	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000223	0.00195	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000219	0.00192	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000215	0.00188	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000215	0.00188	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	0.000214	0.00188	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000214	0.00188	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000211	0.00185	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000211	0.00185	CbGpPWpGaD
Bumetanide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000202	0.00177	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0002	0.00175	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000198	0.00174	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000198	0.00174	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000193	0.00169	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000192	0.00168	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000192	0.00168	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000189	0.00166	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000189	0.00166	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000188	0.00165	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000188	0.00165	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000186	0.00163	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000183	0.00161	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000183	0.0016	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00018	0.00158	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000176	0.00154	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000176	0.00154	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000175	0.00153	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000173	0.00152	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000171	0.0015	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000171	0.0015	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000168	0.00147	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000166	0.00145	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000165	0.00145	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000164	0.00144	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000163	0.00143	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000161	0.00141	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000161	0.00141	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000161	0.00141	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000161	0.00141	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000158	0.00139	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000158	0.00139	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000151	0.00132	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00015	0.00132	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000149	0.00131	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000147	0.00129	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000143	0.00126	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000143	0.00125	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000143	0.00125	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.00014	0.00123	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000138	0.00121	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000137	0.0012	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000136	0.00119	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000134	0.00118	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000134	0.00118	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000133	0.00117	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00013	0.00114	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000129	0.00113	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000128	0.00112	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000127	0.00112	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000124	0.00109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00012	0.00105	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00012	0.00105	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000117	0.00102	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000116	0.00102	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000112	0.000987	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.000942	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000105	0.00092	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000104	0.000911	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000101	0.000887	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.74e-05	0.000854	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.74e-05	0.000854	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	9.55e-05	0.000838	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.54e-05	0.000837	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.44e-05	0.000828	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.44e-05	0.000828	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.29e-05	0.000815	CbGpPWpGaD
Bumetanide—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	9.29e-05	0.000815	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.08e-05	0.000796	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.9e-05	0.000781	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.83e-05	0.000775	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.75e-05	0.000767	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.68e-05	0.000761	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.68e-05	0.000761	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.51e-05	0.000746	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.28e-05	0.000726	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	8.26e-05	0.000725	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.15e-05	0.000715	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.04e-05	0.000705	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	7.85e-05	0.000688	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	7.81e-05	0.000685	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.78e-05	0.000683	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	7.65e-05	0.000671	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.42e-05	0.000651	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.31e-05	0.000642	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.3e-05	0.00064	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	7.21e-05	0.000633	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	7.14e-05	0.000626	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	7.14e-05	0.000626	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	7.04e-05	0.000618	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	7.04e-05	0.000618	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.98e-05	0.000612	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.72e-05	0.00059	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.69e-05	0.000587	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	6.61e-05	0.00058	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.41e-05	0.000562	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	6.37e-05	0.000559	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.11e-05	0.000536	CbGpPWpGaD
Bumetanide—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	5.68e-05	0.000498	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.64e-05	0.000495	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.62e-05	0.000493	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.53e-05	0.000485	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.38e-05	0.000472	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.33e-05	0.000468	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	5.3e-05	0.000465	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	5.27e-05	0.000463	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.24e-05	0.00046	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.18e-05	0.000454	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	4.92e-05	0.000432	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.89e-05	0.000429	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.89e-05	0.000429	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.77e-05	0.000418	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.53e-05	0.000398	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.48e-05	0.000393	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	4.26e-05	0.000374	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.19e-05	0.000367	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	4.07e-05	0.000357	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.04e-05	0.000355	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.79e-05	0.000332	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.69e-05	0.000324	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.61e-05	0.000317	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.6e-05	0.000316	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.6e-05	0.000316	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.31e-05	0.00029	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.96e-05	0.00026	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.92e-05	0.000256	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.72e-05	0.000239	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	2.54e-05	0.000222	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.000191	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000175	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.96e-05	0.000172	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.86e-05	0.000164	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-05	0.000144	CbGpPWpGaD
